Buscar
Mostrando ítems 1-10 de 287
Role of exercise in the mechanisms ameliorating hepatic steatosis in non-alcoholic fatty liver disease
(Springer-Verlag Italia s.r.l., 2018)
The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis
(INFORMA HEALTHCARE, 2011)
Introduction. Hepatic steatosis due to non-alcoholic fatty liver disease is associated with obesity, dyslipidemia, insulin resistance, and type 2 diabetes. The Finnish Diabetes Risk Score (FINDRISC) is a prognostic screening ...
Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis
(2013)
Purpose. To evaluate the accuracy of the sonographic hepatorenal ratio (HRR) in the diagnosis and grading of nonalcoholic steatosis, using biopsy as the reference.
Methods. Ultrasound (US) and liver biopsy were performed ...
Consumo de frutose e exercício físico, impacto na síndrome metabólica
(2010-01-01)
In the last two decades, the metabolic syndrome is in focus of many health agencies worldwide. Understanding among the most important glucose intolerance and insulin resistance, other disorders have been framed in this ...
Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease
(2020-01-01)
Non-alcoholic fatty liver disease (NAFLD) affects around 25% of the worldwide population. Non-alcoholic steatohepatitis (NASH), the more progressive variant of NAFLD, is characterized by steatosis, cellular ballooning, ...
Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease
(2004)
Hepatic steatosis is a major feature associated with NAFLD (non-alcoholic fatty liver disease). The aims of the present study were to assess the levels of PUFA (polyunsaturated fatty acids) in liver total lipids, ...
Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease
(Elsevier B.V., 2018)
© 2018 The global epidemic of obesity has been accompanied by a rising burden of non-alcoholic fatty liver disease (NAFLD), with manifestations ranging from simple steatosis to non-alcoholic steatohepatitis, potentially ...